Pure Health Holding PJSC (ADX:PUREHEALTH)

Pure Health Holding PJSC Income Statement

Financials in millions AED. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	25,848	16,399	12,486
Revenue Growth (YoY)	57.62%	31.34%	-
Cost of Revenue	19,212	12,976	7,656
Gross Profit	6,636	3,423	4,830
Selling, General & Admin	4,659	2,762	2,326
Other Operating Expenses	-632.88	-841.02	-1,378
Operating Expenses	4,026	1,921	948.35
Operating Income	2,610	1,502	3,881
Interest Expense	-825.28	-78.22	-44.56
Other Non Operating Income (Expenses)	-22.36	-39.26	-
EBT Excluding Unusual Items	1,762	1,384	3,837
Impairment of Goodwill	-	-	-0.27
Gain (Loss) on Sale of Investments	56.33	-	-
Gain (Loss) on Sale of Assets	25.37	-0.61	-19.11
Asset Writedown	-65.84	-	-7.01
Other Unusual Items	-	-	475.46
Pretax Income	1,778	1,384	4,286
Income Tax Expense	62.04	418.7	-
Earnings From Continuing Operations	1,716	964.95	4,286
Minority Interest in Earnings	-4.09	-0.29	-567.45
Net Income	1,712	964.66	3,718
Net Income to Common	1,712	964.66	3,718
Net Income Growth	77.44%	-74.06%	-
Shares Outstanding (Basic)	11,111	10,037	9,832
Shares Outstanding (Diluted)	11,111	10,037	9,832
Shares Change (YoY)	10.71%	2.08%	-
EPS (Basic)	0.15	0.10	0.38
EPS (Diluted)	0.15	0.10	0.38
EPS Growth	60.27%	-74.59%	-
Free Cash Flow	3,386	2,142	3,955
Free Cash Flow Per Share	0.30	0.21	0.40
Gross Margin	25.67%	20.87%	38.68%
Operating Margin	10.10%	9.16%	31.09%
Profit Margin	6.62%	5.88%	29.78%
Free Cash Flow Margin	13.10%	13.06%	31.67%
EBITDA	3,480	2,221	4,166
EBITDA Margin	13.46%	13.54%	33.37%
D&A For EBITDA	870.94	719.19	284.93
EBIT	2,610	1,502	3,881
EBIT Margin	10.10%	9.16%	31.09%
Effective Tax Rate	3.49%	30.26%	-

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.